We are live on ! Find out more
BNR

Burning Rock Biotech

85 hedge funds and large institutions have $794M invested in Burning Rock Biotech in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 9

57% more funds holding

Funds holding: 5485 (+31)

25% more capital invested

Capital invested by funds: $635M → $794M (+$159M)

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

0.39% more ownership

Funds ownership: 2.7%3.09% (+0.39%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
85
Holders Change
+31
Holders Change %
+57.41%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
40
Increased
19
Reduced
16
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EFMH
26
E Fund Management (HK)
Hong Kong
$3.13M +$329K +1,113 +12%
Prudential Financial
27
Prudential Financial
New Jersey
$3.11M -$133K -450 -4%
Fidelity Investments
28
Fidelity Investments
Massachusetts
$3.1M -$19.6M -66,260 -86%
Northern Trust
29
Northern Trust
Illinois
$2.9M +$2.91M +9,852 New
PPA
30
Parametric Portfolio Associates
Washington
$2.74M +$2.44M +8,255 +785%
NEI
31
Northwest & Ethical Investments
Ontario, Canada
$2.47M +$846K +2,858 +52%
ICP
32
Indus Capital Partners
New York
$2.42M -$1.75M -5,924 -42%
Vanguard Group
33
Vanguard Group
Pennsylvania
$2.35M +$2.36M +7,972 New
DCM
34
Driehaus Capital Management
Illinois
$2.22M -$4.64M -15,690 -68%
Goldman Sachs
35
Goldman Sachs
New York
$2.21M -$18M -60,996 -89%
Bank of America
36
Bank of America
North Carolina
$2.09M +$1.13M +3,806 +115%
UBS Group
37
UBS Group
Switzerland
$2.06M +$2.07M +7,005 New
N
38
Nuveen
North Carolina
$2.04M +$2.05M +6,940 New
Deutsche Bank
39
Deutsche Bank
Germany
$1.95M +$1.96M +6,621 New
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.9M +$1.91M +6,445 New
N
41
Natixis
France
$1.74M -$29K -98 -2%
UBS AM
42
UBS AM
Illinois
$1.53M +$1.54M +5,203 New
Bessemer Group
43
Bessemer Group
New Jersey
$1.49M +$1.49M +5,044 New
PAMU
44
Pictet Asset Management (UK)
United Kingdom
$1.44M +$1.45M +4,900 New
CS
45
Credit Suisse
Switzerland
$1.36M +$1.36M +4,608 New
Citigroup
46
Citigroup
New York
$1.33M +$1.23M +4,145 +1,139%
SG Americas Securities
47
SG Americas Securities
New York
$1.19M +$583K +1,970 +95%
Citadel Advisors
48
Citadel Advisors
Florida
$1.13M -$2.01M -6,780 -64%
Los Angeles Capital Management
49
Los Angeles Capital Management
California
$1.12M +$1.12M +3,799 New
TD Asset Management
50
TD Asset Management
Ontario, Canada
$1.07M

BNR Hedge Fund Activity: Q2 2021 in Review

85 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q2 2021, worth a combined $794M — up 25% from $635M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new BNR positions and 9 closed out — a net gain of 31 holders — while 19 added to existing stakes and 16 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $55.6M. The largest seller was Casdin Capital, exiting entirely with an estimated $22.8M sold.

  • 85 institutional investors held Burning Rock Biotech (BNR) as of Q2 2021, up from 54 in Q1 2021.
  • Funds reported $794M of Burning Rock Biotech stock for Q2 2021, up 25% quarter-over-quarter.
  • 40 funds opened new Burning Rock Biotech positions in Q2 2021 and 9 closed out, a net change of +31 holders.
  • The largest Burning Rock Biotech buyer in Q2 2021 was Baillie Gifford & Co, an estimated $55.6M added.
  • The largest Burning Rock Biotech seller in Q2 2021 was Casdin Capital, an estimated $22.8M sold.

Based on aggregated 13F filings for Q2 2021.